Humalog®

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

HUMALOG® (insulin lispro) 200 units/mL: Administration

Humalog (insulin lispro) 200 units/mL is available as a 3 mL KwikPen for subcutaneous use.

Humalog® (insulin lispro) 200 units/mL is available only as a 3 mL KwikPen® for subcutaneous use (Humalog Package Insert, 2015).

Administration (Humalog Package Insert, 2015)

  • Administer the dose of insulin lispro 200 units/mL within 15 minutes before a meal or immediately after a meal by injection into the subcutaneous tissue of the abdominal wall, thigh, upper arm, or buttocks.

  • Do not administer insulin lispro 200 units/mL using a continuous subcutaneous infusion pump (eg, insulin pump).

  • Do not administer insulin lispro 200 units/mL by intravenous infusion.

  • Do not mix insulin lispro 200 units/mL with any other insulins.

  • Do not transfer insulin lispro 200 units/mL from the KwikPen to a syringe as the markings on the insulin syringe will not measure the dose correctly and can result in overdosage and severe hypoglycemia.

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

The published reference below is available upon request by contacting 1-800-LillyRx.

Reference

Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2015.

Additional related information

Date of Last Review: March 13, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical